ClinicalTrials.gg
CompletedNCT01277081Updated Feb 18, 2015Results posted

Effect of Paracetamol on the Common Cold

A Phase 2 interventional study of Paracetamol hot drink and Paracetamol tablets in Common Cold, sponsored by GlaxoSmithKline. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-02-18.

Sponsored by GlaxoSmithKline · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 20 studies in Common Cold with a site in United Kingdom — none open to participants now, 1 under way, none of them phase 3. Common Cold · United Kingdom.

Enrollment
6th of 20
200 · median 89
Started
2010
the only one that year
Phase 2
4 of 20
none open now
Registered
4th of 20
by date
Lead sponsor
4 of 20
GlaxoSmithKline

Among the 20 studies in Common Cold with a site in United Kingdom, this one is the 6th largest by enrollment, is the only one that started in 2010, is one of 4 in phase 2, and was the 4th registered.

Common Cold

219 studies on the registry are indexed under Common Cold; 23 are open to participants now.

Browse Common Cold studies →

Open to participants now

None of the 20 studies in Common Cold with a site in United Kingdom is open now. The open studies under Common Cold, anywhere →

Who these studies take

Of the 14 Common Cold studies recruiting now, 4 (29%) set no upper age limit and 9 (64%) stop at 75 or younger; 4 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 20 studies in Common Cold with a site in United Kingdom as a file.
02

Study summary

The aim of this study is to subjectively assess symptoms in subjects suffering from the common cold following a single dose of paracetamol hot drink compared to paracetamol tablet

03

Conditions studied

  • Common Cold

Browse trials for

Keywords

  • Paracetamol
  • Common cold
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Symptoms of the common cold of no more than 120 hours duration
  • Self-rating congestion of at least moderate severity
  • Suffering from at least four symptoms of common cold or flu
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (actual)

Study arms

  • Active comparator
    Paracetamol hot drink

    Hot drink containing paracetamol

    Drug: Paracetamol hot drink

  • Active comparator
    Paracetamol tablets

    Paracetamol tablets

    Drug: Paracetamol tablets

Interventions

  • DrugParacetamol hot drink

    Hot drink containing paracetamol

  • Paracetamol tablets

06

What researchers measure

Primary outcomes

  1. Breathing Scores Post 15 Minutes

    A mean breathing score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

    Time frame: Baseline to 15 minutes

Secondary outcomes

  1. Breathing Score Post 60 Minutes

    A mean breathing score was calculated at baseline, 30 seconds, 2, 5, 15 and 60 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

    Time frame: Baseline to 60 minutes

  2. Cold Symptoms Score Post 15 Minutes

    A mean Cold symptom score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes from participant responses to questions relating to cold symptoms i.e. "My head feels clear", "I feel soothing in my throat" and "I feel my cough is being soothed". The cold symptom scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

    Time frame: Baseline to 15 minutes

  3. Cold Symptoms Score Post 60 Minutes

    A mean Cold symptom score was calculated at baseline, 30 seconds, 2, 5, 15 and 60 minutes from participant responses to questions relating to cold symptoms i.e. "My head feels clear", "I feel soothing in my throat" and "I feel my cough is being soothed". The cold symptom scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

    Time frame: Baseline to 60 minutes

  4. Soothing Attribute Scores

    Soothing attribute of test treatment was assessed by asking the question "if the hot drink is soothing" at baseline, 15 and 60 minutes. The response to the question was rated by participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'.

    Time frame: Baseline to 15 and 60 minutes

  5. Overall Cold Symptoms Score

    Overall cold symptom score was assessed by asking the question "my cold symptoms are improved" only post consuming the drink at baseline, 15 and 60 minutes . The response to the question was rated by participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'.

    Time frame: Baseline to 15 and 60 minutes

07

Results

Posted Feb 18, 2015

Participant flow

Participants were recruited at the clinical site.

Participant flow — Overall Study
MilestoneMentholated Paracetamol Hot DrinkParacetamol Tablet
Started100100
Completed100100
Not completed00

Outcome measures

PrimaryBreathing Scores Post 15 Minutes

A mean breathing score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

Time frame:
Baseline to 15 minutes
Reported as:
Mean · Score on a Scale
Breathing Scores Post 15 Minutes
Score on a ScaleMentholated Paracetamol Hot DrinkParacetamol Tablet
Breathing Scores Post 15 Minutes0.83 (0.73 to 0.93)0.11 (0.01 to 0.21)
Statistical analysis
  • Mentholated Paracetamol Hot Drink vs Paracetamol Tablet · Repeated Measure Analysis · p = <0.0001 · Adjusted mean difference: 0.72 · 95% CI 0.58 to 0.86Difference was first named treatment minus second named treatment such that a positive difference favours the first named treatment
SecondaryBreathing Score Post 60 Minutes

A mean breathing score was calculated at baseline, 30 seconds, 2, 5, 15 and 60 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

Time frame:
Baseline to 60 minutes
Reported as:
Mean · Score on a scale
Breathing Score Post 60 Minutes
Score on a scaleMentholated Paracetamol Hot DrinkParacetamol Tablet
Breathing Score Post 60 Minutes0.92 (0.81 to 1.02)0.34 (0.23 to 0.44)
Statistical analysis
  • Mentholated Paracetamol Hot Drink vs Paracetamol Tablet · Repeated measures analysis · p = <0.0001 · Adjusted mean difference: 0.58 · 95% CI 0.44 to 0.72Difference was first named treatment minus second named treatment such that a positive difference favours the first named treatment.
SecondaryCold Symptoms Score Post 15 Minutes

A mean Cold symptom score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes from participant responses to questions relating to cold symptoms i.e. "My head feels clear", "I feel soothing in my throat" and "I feel my cough is being soothed". The cold symptom scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

Time frame:
Baseline to 15 minutes
Reported as:
Mean · Score on a scale
Cold Symptoms Score Post 15 Minutes
Score on a scaleMentholated Paracetamol Hot DrinkParacetamol Tablet
Cold Symptoms Score Post 15 Minutes0.64 (0.52 to 0.75)0.13 (0.02 to 0.25)
Statistical analysis
  • Mentholated Paracetamol Hot Drink vs Paracetamol Tablet · Repeated measures analysis · p = <0.0001 · Adjusted mean difference: 0.50 · 95% CI 0.36 to 0.65Difference was first named treatment minus second named treatment such that a positive difference favours the first named treatment.
SecondaryCold Symptoms Score Post 60 Minutes

A mean Cold symptom score was calculated at baseline, 30 seconds, 2, 5, 15 and 60 minutes from participant responses to questions relating to cold symptoms i.e. "My head feels clear", "I feel soothing in my throat" and "I feel my cough is being soothed". The cold symptom scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.

Time frame:
Baseline to 60 minutes
Reported as:
Mean · Score on a scale
Cold Symptoms Score Post 60 Minutes
Score on a scaleMentholated Paracetamol Hot DrinkParacetamol Tablet
Cold Symptoms Score Post 60 Minutes0.87 (0.76 to 0.99)0.35 (0.24 to 0.46)
Statistical analysis
  • Mentholated Paracetamol Hot Drink vs Paracetamol Tablet · Repeated measures analysis · p = <0.0001 · Adjusted mean difference: 0.52 · 95% CI 0.38 to 0.67Difference was first named treatment minus second named treatment such that a positive difference favours the first named treatment.
SecondarySoothing Attribute Scores

Soothing attribute of test treatment was assessed by asking the question "if the hot drink is soothing" at baseline, 15 and 60 minutes. The response to the question was rated by participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'.

Time frame:
Baseline to 15 and 60 minutes
Reported as:
Mean · Score on a scale
Soothing Attribute Scores
Score on a scaleMentholated Paracetamol Hot DrinkParacetamol Tablet
Average effect over first 15 minutes2.3 ± 0.801.2 ± 0.88
Average effect over 60 minutes2.4 ± 0.721.3 ± 0.88
SecondaryOverall Cold Symptoms Score

Overall cold symptom score was assessed by asking the question "my cold symptoms are improved" only post consuming the drink at baseline, 15 and 60 minutes . The response to the question was rated by participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'.

Time frame:
Baseline to 15 and 60 minutes
Reported as:
Mean · Score on a scale
Overall Cold Symptoms Score
Score on a scaleMentholated Paracetamol Hot DrinkParacetamol Tablet
Average effect over first 15 minutes1.8 ± 0.860.9 ± 0.63
Average effect over 60 minutes2.1 ± 0.751.3 ± 0.62

Adverse events

Collected over Adverse events were collected from the start of the treatment, and until 5 days following administration of the last dose of investigational product.. Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mentholated Paracetamol Hot Drink—0/100 (0%)0/100 (0%)
Paracetamol Tablets—0/100 (0%)0/100 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Mentholated Paracetamol Hot DrinkParacetamol TabletTotal
Mean20.0 ± 1.8520.0 ± 1.9820.0 ± 1.92
Sex: Female, Male
Sex: Female, Male(Participants)Mentholated Paracetamol Hot DrinkParacetamol TabletTotal
Female6563128
Male353772
08

Study locations

1 site
  • Common Cold Centre
    Cardiff, Wales, United Kingdom
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2010, a primary completion of Dec 2010 and a completion of Dec 2010. It does not say whether these dates are actual or estimated.

Results were first posted in Feb 2015, 4 years 2 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2011
First posted
Jan 14, 2011
Start
Oct 2010
Primary completionActual
Dec 2010
CompletionActual
Dec 2010
Results first posted
Feb 18, 2015
Last update
Feb 18, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 18, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01277081
Lead sponsor
GlaxoSmithKline
Responsible party
Sponsor
First posted
Jan 14, 2011
Start date
Oct 2010
Primary completion
Dec 2010
Completion
Dec 2010
Results posted
Feb 18, 2015
Last update
Feb 18, 2015

Study contacts

GSK Clinical Trials
study director · GlaxoSmithKline

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Acetaminophen

Start the discussion